Abstract
Background: Many people with end-stage chronic kidney disease continued attending clinical centres for dialysis despite the risk of contracting COVID-19 and developing severe disease. Aims: To assess the impact of COVID-19 on patients' adjustment and wellbeing. Methods: Some 40 people (18 female, 22 male) receiving in-centre haemodialysis reported COVID-19-related adverse impacts on treatment and rated their COVID-19-related concerns, then completed the Depression, Anxiety and Stress Scale-21 and four scales of the Kidney Disease Quality of Life Short Form. Findings: The most common adverse impacts were staff shortages/changes and impaired interaction with staff/patients. Of the sample, 32.4% were severely depressed, 14.7% severely anxious and 18.9% severely stressed. Participants who had tested positive for COVID-19 were more depressed and reported more adverse impacts. Older and married/cohabiting participants had better adjustment and wellbeing. Conclusions: The results help to identify patients with the greatest needs and suggest ways to maintain patient wellbeing during outbreaks of infectious disease.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
